SCHEMBL8637124

SCHEMBL8637124

Cc1ccc(-c2c(C(F)(F)F)nn(-c3ccccc3)c2-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 16/20 0.64
PTGS1 P23219 13/20 0.64
PDPK1 O15530 3/20 0.55
CYP2C9 P11712 2/20 0.55
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
CA4 P22748 2/20 0.55
CA9 Q16790 2/20 0.55
PTGES O14684 1/20 0.55
HDAC3 O15379 1/20 0.55
CA12 O43570 1/20 0.55
PDE5A O76074 1/20 0.55
ABCB11 O95342 1/20 0.55
MT-CO2 P00403 1/20 0.55
LMNA P02545 1/20 0.55
CA3 P07451 1/20 0.55
CYP3A4 P08684 1/20 0.55
ALOX5 P09917 1/20 0.55
ADORA3 P0DMS8 1/20 0.55
CYP2D6 P10635 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8637873 0.97 PTGS2 (0.69) PTGS2PTGS1PDPK1CYP2C9CA1
SCHEMBL8765415 0.94 PTGS2 (0.67) PTGS2PTGS1PDPK1CYP2C9CA1
SCHEMBL8764637 0.93 PTGS2 (0.72) PTGS2PTGS1PDPK1
Dimethylamine SCHEMBL8635160 0.91 PTGS2 (0.67) PTGS2PTGS1PDPK1
SCHEMBL8639318 0.91 PTGS2 (0.64) PTGS2PTGS1PDPK1
SCHEMBL8635155 0.90 PTGS2 (0.65) PTGS2PTGS1PDPK1CYP2C9
SCHEMBL8765218 0.90 PTGS2 (0.54) PTGS2PTGS1CYP2C9CYP2D6
SCHEMBL8607525 0.90 PTGS2 (0.65) PTGS2PTGS1PDPK1CA1CA2
SCHEMBL8635532 0.90 PTGS2 (0.68) PTGS2PTGS1PDPK1CA1CA2
SCHEMBL8638187 0.90 PTGS2 (0.65) PTGS2PTGS1PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 EP claimed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 US claimed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 EP claimed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 WO claimed
EP-0830133-A1 THERAPEUTIC COMPOSITION FOR ARTHRITIS Takeda Chemical Industries, Ltd. (JP) 1998-03-25 EP disclosed
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 EP disclosed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 US disclosed
WO-1996033717-A1 THERAPEUTIC COMPOSITION FOR ARTHRITIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-10-31 WO disclosed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 EP disclosed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed